Integrated transcriptomic and functional analyses identify PRR7 as a therapeutic target that associated with Wnt/β-catenin signaling and docetaxel resistance in prostate cancer
Wei Sun, Yuheng Si, Lu Hong, Qingxiang Guo et autres
cn (code pays fourni par la source)
0 citations
Biochemical and Biophysical Research Communications